Medicare Enrolled
Dr. Sami Moshi, MD
Neurology · Lodi, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Moshi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Moshi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Moshi
Dr. Sami Moshi is a neurology specialist in Lodi, CA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Moshi performed 18,084 Medicare services across 981 unique beneficiaries.
Between the years covered by Open Payments, Dr. Moshi received a total of $20,334 from 76 pharmaceutical and/or device companies across 1156 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Moshi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice
▲ Top 6% volume in CA
$20,334 industry payments
Medicare Practice Summary
Medicare Utilization ↗18,084
Medicare services
Top 6% in CA for neurology
981
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,391 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
16,720 | $5 | $14 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
522 | $92 | $280 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
167 | $139 | $392 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
137 | $97 | $211 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
127 | $125 | $360 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
111 | $64 | $147 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
65 | $119 | $399 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
63 | $103 | $278 |
| New patient office visit, complex (60-74 min) | 44 | $180 | $476 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
43 | $138 | $408 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
29 | $46 | $149 |
| Telephone or internet assessment, 11-20 minutes A remote consultation conducted via telephone or internet that includes verbal discussion and a written report, lasting between 11 and 20 minutes. |
26 | $28 | $75 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
19 | $64 | $198 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
11 | $108 | $369 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$20,334
Total received (2018-2024)
Avg $2,905/year across 7 years
Top 15% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
76
Companies
1,156
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,334 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,868
2023
$3,523
2022
$5,057
2021
$2,804
2020
$1,590
2019
$1,404
2018
$1,088
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
MDD US Operations, LLC
$628
ABBVIE INC.
$436
UCB, Inc.
$395
Biogen, Inc.
$262
SK Life Science, Inc.
$245
Eisai Inc.
$241
Alexion Pharmaceuticals, Inc.
$232
Neurocrine Biosciences, Inc.
$223
PFIZER INC.
$163
Otsuka America Pharmaceutical, Inc.
$159
Lilly USA, LLC
$157
Celgene Corporation
$156
Amgen Inc.
$153
ARGENX US, INC.
$138
Novartis Pharmaceuticals Corporation
$121
ACADIA Pharmaceuticals Inc
$107
JAZZ PHARMACEUTICALS INC.
$107
LivaNova USA, Inc.
$102
Neurelis, Inc.
$77
Aucta Pharmaceuticals, Inc.
$72
GE HEALTHCARE
$66
Takeda Pharmaceuticals U.S.A., Inc.
$64
Amneal Pharmaceuticals LLC
$58
Lundbeck LLC
$58
Kyowa Kirin, Inc.
$57
Genentech USA, Inc.
$56
Vanda Pharmaceuticals Inc.
$53
Merz Pharmaceuticals, LLC
$45
Kedrion Biopharma, Inc.
$38
BANNER LIFE SCIENCES, LLC
$32
Averitas Pharma Inc.
$29
MITSUBISHI TANABE PHARMA AMERICA, INC.
$27
Boehringer Ingelheim Pharmaceuticals, Inc.
$27
Abbott Laboratories
$22
Octapharma USA, Inc.
$21
CSL Behring
$16
SCILEX PHARMACEUTICALS INC.
$14
EMD Serono, Inc.
$14
Top 3 companies account for 30.0% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,924
UCB, Inc.
$1,596
Biogen, Inc.
$1,338
GENZYME CORPORATION
$1,044
SK Life Science, Inc.
$732
Amgen Inc.
$730
MDD US Operations, LLC
$688
Lilly USA, LLC
$688
Amneal Pharmaceuticals LLC
$633
Neurocrine Biosciences, Inc.
$630
Alexion Pharmaceuticals, Inc.
$602
EMD Serono, Inc.
$525
ACADIA Pharmaceuticals Inc
$523
Eisai Inc.
$522
Novartis Pharmaceuticals Corporation
$521
Allergan, Inc.
$461
PFIZER INC.
$425
Biohaven Pharmaceutical Holding Company Ltd.
$421
Teva Pharmaceuticals USA, Inc.
$406
Genentech USA, Inc.
$386
Boehringer Ingelheim Pharmaceuticals, Inc.
$366
SANOFI-AVENTIS U.S. LLC
$339
IMPEL PHARMACEUTICALS INC.
$310
ARGENX US, INC.
$307
Celgene Corporation
$306
LivaNova USA, Inc.
$251
Otsuka America Pharmaceutical, Inc.
$229
Adamas Pharmaceuticals, Inc.
$226
Neurelis, Inc.
$209
Avanir Pharmaceuticals, Inc.
$195
Janssen Pharmaceuticals, Inc
$173
AbbVie Inc.
$154
Lundbeck LLC
$142
Horizon Therapeutics plc
$136
JAZZ PHARMACEUTICALS INC.
$129
Biohaven Pharmaceuticals, Inc.
$122
Supernus Pharmaceuticals, Inc.
$119
Takeda Pharmaceuticals U.S.A., Inc.
$110
Merz Pharmaceuticals, LLC
$109
Kyowa Kirin, Inc.
$107
Novo Nordisk Inc
$86
EISAI INC.
$85
Acorda Therapeutics, Inc
$75
Aucta Pharmaceuticals, Inc.
$72
Mannkind Corporation
$71
GE HEALTHCARE
$66
Grifols USA, LLC
$60
Becton, Dickinson and Company
$58
Impax Laboratories, Inc.
$56
Banner Life Sciences, LLC
$55
Vanda Pharmaceuticals Inc.
$53
Merck Sharp & Dohme Corporation
$50
BANNER LIFE SCIENCES, LLC
$50
Sumitomo Pharma America, Inc.
$47
Abbott Laboratories
$46
Akcea Therapeutics, Inc.
$45
Catalyst Pharmaceuticals, Inc.
$43
Averitas Pharma Inc.
$42
Greenwich Biosciences, Inc.
$41
Octapharma USA, Inc.
$40
Kedrion Biopharma, Inc.
$38
CeQur Corporation
$32
CSL Behring
$29
MITSUBISHI TANABE PHARMA AMERICA, INC.
$27
Jazz Pharmaceuticals Inc.
$25
Exeltis, USA Inc.
$25
BioTissue Holdings, Inc.
$23
GE HealthCare
$23
Medtronic, Inc.
$22
Cala Health, Inc.
$21
CATALYST PHARMACEUTICALS, INC.
$16
DEXCOM, INC.
$16
Merz North America, Inc.
$16
Xeris Pharmaceuticals, Inc.
$16
SCILEX PHARMACEUTICALS INC.
$14
IDORSIA PHARMACEUTICALS US INC
$13
Top 3 companies account for 23.9% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AFINITOR · AFREZZA · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Albuked · Apokyn · Austedo XR · BAFIERTAM · BAQSIMI · BD Nano · BD Nano 2nd Gen Pen Needle · BOTOX · Briviact · CALA KIQ · COMIRNATY · COPAXONE · CeQur Simplicity · Crysvita · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · DUOPA · Dayvigo · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · FIRDAPSE · Fintepla · FreeStyle Libre · Fycompa · GILENYA · GOCOVRI · GVOKE PFS · Gamunex-C · Gocovri · HETLIOZ · HYQVIA · Hizentra · INBRIJA · INFINITY · INGREZZA · JANUVIA · JARDIANCE · KESIMPTA · KISUNLA · LANTUS · LEMTRADA · LEQEMBI · Leqembi · MAVENCLAD · MAYZENT · MINIMED 770G · Mavenclad · Motpoly XR · NEOX · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · ONGENTYS · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PAXLOVID · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · QUTENZA · QUVIVIQ · RADICAVA · REXULTI · REYVOW · RYTARY · Rebif · Rystiggo · SOLIQUA 100/33 · STEGLATRO · STRENSIQ · SYNTHROID · Soliris · Strensiq · TECFIDERA · TEGSEDI · TEPEZZA · TOUJEO · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XCOPRI · XEOMIN · Xeomin · ZAVZPRET · ZEPOSIA · ZTLido · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
17
Per 100K population
2.2
County median income
$88,531
Nearest hospital
ADVENTIST HEALTH LODI MEMORIAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Moshi is a mixed practice specialist, with above-average Medicare volume (top 6% in CA), with low-engagement industry engagement in the top 15% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Moshi experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Moshi performed 16,720 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Moshi receive payments from pharmaceutical companies?
Yes. Dr. Moshi received a total of $20,334 from 76 companies across 1,156 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Moshi's costs compare to other neurologists in Lodi?
Dr. Moshi's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Moshi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Lodi
Browse neurologists in Lodi ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology